Biotech interviews demand mastery of drug development strategy, clinical evidence evaluation, and innovation management. Whether you're interviewing for strategy, product, business development, or operations roles, you need frameworks to tackle complex biotech challenges — from portfolio prioritization and regulatory pathways to manufacturing economics and market opportunity.
Biotech Interview prepares you to think like a biotech strategist. Practice decomposing drug development decisions, analyze pipeline trade-offs across clinical efficacy and commercial viability, and build the biotech business literacy that distinguishes top candidates.
How it works
- Practice biotech cases modeled on real interview questions from Pfizer, Merck, Amgen, Regeneron, and Eli Lilly
- Get AI-powered feedback on your drug development strategy, regulatory insight, and commercialization frameworks
- Build skills across pipeline management, clinical trial design, competitive analysis, and manufacturing economics
- Track your progress across 20+ biotech competencies with adaptive difficulty
Why biotech interviews need dedicated prep
Generic business case prep doesn't work for biotech. Biotech interviews layer clinical complexity, regulatory constraints, and R&D risk on top of business analysis. You need frameworks that integrate Phase trial success rates with investment decisions, that connect scientific differentiation to market advantage, and that reflect the data-driven, innovation-focused culture of biotech leadership.
The AI coach pushes you in biotech-specific ways — asking you to defend indication selection trade-offs, evaluate patent cliffs and pricing pressure, and articulate how you balance scientific breakthrough potential with commercial viability.
Built for aspiring biotech professionals
Whether you're transitioning into biotech strategy, pursuing a commercial role at a pharma company, or building expertise in drug development finance, Biotech Interview meets you where you are. Candidates preparing for roles at biotech companies, pharmaceutical giants, and healthcare investment firms all find frameworks relevant to their target companies.